Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Mr. Christophe Weber is the President of Takeda Pharmaceutical Co Ltd, joining the firm since 2014.
What is the price performance of Takeda Pharmaceutical Company L stock?
The current price of Takeda Pharmaceutical Company L is $15.91, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Takeda Pharmaceutical Co Ltd?
Takeda Pharmaceutical Co Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Takeda Pharmaceutical Co Ltd market cap?
Takeda Pharmaceutical Co Ltd's current market cap is $50.2B
Is Takeda Pharmaceutical Co Ltd a buy, sell, or hold?
According to wall street analysts, 16 analysts have made analyst ratings for Takeda Pharmaceutical Co Ltd, including 3 strong buy, 7 buy, 8 hold, 0 sell, and 3 strong sell